Segall Bryant & Hamill »

Celldex Therapeutics shares owned by Segall Bryant & Hamill

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Segall Bryant & Hamill from 13F filings

Historical chart of Segall Bryant & Hamill investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Segall Bryant & Hamill consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Segall Bryant & Hamill

Quarter filed Position value Share count Share price at filing
2025-09-30 $14M 529k 25.87
2025-06-30 $7.9M 388k 20.35